Viridian Therapeutics, Inc. (VRDN)

NASDAQ: VRDN · Real-Time Price · USD

17.62

+0.17 (0.97%)

At close: May 29, 2026, 4:00 PM EDT

17.10

-0.52 (-2.95%)

After-hours: May 29, 2026, 7:52 PM EDT

Viridian Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,946	3,614	1,911	1,176	1,207	473
Market Cap Growth	92.63%	89.15%	62.49%	-2.55%	155.10%	579.54%
Enterprise Value	1,237	2,921	1,402	925.17	928.79	409.85
Last Close Price	17.62	31.12	19.17	21.78	29.21	19.77
PS Ratio	27.44	51.01	6326.31	3744.64	680.90	159.63
PB Ratio	3.58	5.00	2.84	2.66	3.05	2.52
P/TBV Ratio	2.49	3.65	1.94	2.21	2.37	1.25
EV/Sales Ratio	17.44	41.23	4643.80	2946.40	524.15	138.32
Debt / Equity Ratio	0.08	0.07	0.03	0.05	0.01	0
Net Debt / Equity Ratio	-1.12	-1.14	-1.04	-1.03	-1.06	-1.05
Net Debt / EBITDA Ratio	1.85	2.27	2.34	1.80	3.14	2.48
Net Debt / FCF Ratio	2.34	2.98	2.99	2.47	2.27	2.08
Asset Turnover	0.08	0.09	0.00	0.00	0.01	0.02
Quick Ratio	14.71	12.37	14.99	17.93	12.73	14.48
Current Ratio	15.15	12.65	15.43	18.26	12.93	14.68
Return on Equity (ROE)	-53.10%	-49.16%	-48.48%	-56.80%	-44.57%	-51.61%
Return on Assets (ROA)	-45.69%	-44.27%	-48.51%	-54.99%	-42.05%	-47.60%
Return on Invested Capital (ROIC)	1088.02%	1053.55%	1645.40%	1420.99%	922.32%	1193.53%
Return on Capital Employed (ROCE)	-49.26%	-47.71%	-51.63%	-58.80%	-45.39%	-51.33%
Buyback Yield / Dilution	-23.41%	-24.92%	-51.68%	-39.48%	-169.22%	-235.07%
Total Shareholder Return	-23.41%	-24.92%	-51.68%	-39.48%	-169.22%	-235.07%

SEC Filings: 10-K · 10-Q